Evelo Biosciences
ClosedCambridge, United States · Founded 2015
- Headquarters
- Cambridge, Massachusetts
- Employees
- 51–200
- Founded
- 2015
- Business Model
- B2B
- Website
- evelobio.com
About
Evelo Biosciences is a clinical-stage biotechnology company developing orally delivered medicines that act on SINTAX, the small intestinal axis, to treat a range of inflammatory and immune-mediated diseases. Headquartered in Cambridge, Massachusetts, Evelo's monoclonal microbial product candidates are designed to computationally identify single strains of gut bacteria intended to have a systemic effect on the immune system without being absorbed into the bloodstream.
Summary
Evelo Biosciences is a Biotech company based in Cambridge, United States, founded in 2015.
Tech & App Stack
7 technologies & apps tracked
Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.